Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000020 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 25, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
4,350
Total Value
$37,758.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 23, 2026 | Exercise/Conversion | 1,450 | $8.04 | $11,658.00 | 53,226 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 23, 2026 | Sale | 1,450 | $18.00 | $26,100.00 | 51,776 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 23, 2026 | Exercise/Conversion | 1,450 | $0.00 | $0.00 | 116,871 | Direct | โ | View Details |